What do systematic reviews say?

Sliding scale insulin vs basal‐bolus insulin

Sliding scale insulin showed no clear difference in all‐cause mortality (N) compared with basal‐bolus insulin (low certainty).

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  Peto OR 0.5 [0.05, 4.85]
  4 studies · 602 participants
  Low

Sliding scale insulin vs basal‐bolus insulin

The review found no eligible studies for this question.

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sliding scale insulin vs basal‐bolus insulin

It is very uncertain whether sliding scale insulin changes severe hypoglycaemic episodes (N) compared with basal‐bolus insulin (very low certainty).

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  RR 0.22 [0.05, 1]
  5 studies · 667 participants
  Very low

Sliding scale insulin vs basal‐bolus insulin

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 717 participants
  Very low

Sliding scale insulin vs basal‐bolus insulin

It is very uncertain whether sliding scale insulin changes adverse events other than hypoglycaemic episodes (postoperative… compared with basal‐bolus insulin (very low certainty).

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  RR 1.16 [0.25, 5.37]
  3 studies · 481 participants
  Very low

Sliding scale insulin vs basal‐bolus insulin

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  no estimate extracted
  6 studies · 717 participants
  Low

Sliding scale insulin vs basal‐bolus insulin

The review found no eligible studies for this question.

• Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Laparoscopic retroperitoneal adrenalectomy vs laparoscopic transperitoneal adrenalectomy

• Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults 2018 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 164 participants
  Low

Laparoscopic retroperitoneal adrenalectomy vs laparoscopic transperitoneal adrenalectomy

It is very uncertain whether laparoscopic retroperitoneal adrenalectomy changes early morbidity (any complication during the first 30 to 60 days… compared with laparoscopic transperitoneal adrenalectomy (very low certainty).

• Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults 2018 · Cochrane Headline outcomes only
  RR 0.56 [0.27, 1.16]
  5 studies · 244 participants
  Very low

Laparoscopic retroperitoneal adrenalectomy vs laparoscopic transperitoneal adrenalectomy

It is very uncertain whether laparoscopic retroperitoneal adrenalectomy changes late morbidity (any complication following surgery at latest available compared with laparoscopic transperitoneal adrenalectomy (very low certainty).

• Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults 2018 · Cochrane Headline outcomes only
  RR 0.12 [0.01, 0.92]
  3 studies · 146 participants
  Very low

Laparoscopic retroperitoneal adrenalectomy vs laparoscopic transperitoneal adrenalectomy

The review found no eligible studies for this question.

• Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Laparoscopic retroperitoneal adrenalectomy vs laparoscopic transperitoneal adrenalectomy

• Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults 2018 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 102 participants
  Very low

Intervention not reported

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate

Intervention not reported

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  23 participants
  Moderate

Intervention not reported

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate

Intervention not reported

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  31 participants
  Moderate

Intervention not reported

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate

Intervention not reported

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  Moderate

Summary of findings: risk of intermediate hyperglycaemia (IFG5.6 mmol/L definition) vs normoglycaemia

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  2385 participants
  Low

Summary of findings: risk of intermediate hyperglycaemia (IFG5.6 mmol/L definition) vs normoglycaemia

• Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia 2018 · Cochrane Headline outcomes only
  no estimate extracted
  5685 participants
  Low